Faculty

 

Pharmacology

 

Head of Department: Prof. Anita Kotwani

 

1. Dr Anita Kotwani, Direactor Professor

 

Appointments and job profile

 

Anita Kotwani is Professor and Head of Pharmacology Department at V. P. Chest Institute, University of Delhi, India. She is actively engaged in research including basic, applied and population medicine. Her teaching responsibilities involve supervision of PhD and MD students engaged in basic and clinical research.

 

Prior to this appointment, she taught M.B.B.S. M.D. and B.D.S. students at Maulana Azad Medical College, New Delhi till 2005.

 

Recently Dr. Kotwani was on short term assignment for one year at World Health Organization, South –East-Asian Region Office at New Delhi (till July 2016) as Technical Officer – Essential Drugs and Medicines. AT WHO, Dr. Kotwani provided Technical support to Member States for Essential Drugs, Medicine Management and was Focal Point from the Department of Health Systems and Development for Task Force on Anti-Microbial Resistance of South-East Asian Regional Office (SEARO). During her tenure at WHO, she conducted situation analysis of medicine management in healthcare system in three countries – Bhutan, Thailand and Timor-Leste. She has conducted situation analysis in Maldives, Timor-Leste and Sri Lanka for aligning National Action Plan with the Global Action Plan on Antimicrobial resistance.

 

Area of research

 

She is a pharmacologist with primary interests in how clinical and basic sciences are translated into clinical practice and health policy. Her research also involves multisectoral partners to promote population health beyond the goals of care of the individual treated. Her areas of expertise are National Medicine Policy, Surveillance of antimicrobial medicines and consumption in the community and containment of antimicrobial resistance, Qualitative studies for behavior of antibiotic use, Access to essential medicines, Rational use of medicines, Drug utilization studies, Medicine management in healthcare system and Chronic diseases.

 

Her research focuses on antibiotic use and consumption in humans in the community. In collaboration with WHO, Dr. Kotwani has developed a practical methodology that monitors antimicrobial use in the community, which is especially useful in resource-poor settings. She has also conducted qualitative studies of various stakeholders (doctors, pharmacists, high school teachers & students and community) to ascertain antibiotic-use-related behaviour; such studies are needed for development of effective intervention strategies including policy development for appropriate use of antibiotics. Dr. Kotwani has expertise in measuring medicine prices, availability, affordability and price components in public and private sector.  Additionally, Dr. Kotwani also conducts research on quality of care for asthma patients. She studied baseline asthma management in New Delhi and conducted an intervention study as well as adherence and self-management patterns among patients. She has studied effect of Indian almond and Sweet almond on diabetes and diabetes-induced retinopathy and nephropathy in diabetic rat model.

 

Few recent professional achievements

 

  • Anita Kotwani is member of Core Working Group and Technical Advisory Group constituted by Ministry of Health & Family Welfare, Government of India on AMR to oversee and coordinate policy decisions and activities relating to AMR and National Action Plan.

 

  • Dr. Kotwani provided technical support to Timor-Leste to develop IEC material for increasing awareness about appropriate use of antibiotics and antimicrobial resistance involving one-health approach and training for methodology for surveillance of antibiotic consumption in public and private sector. 2018

 

  • Member of the advisory group on “Fair Medicine Pricing Forum” of WHO.

 

  • Technical advisor for ‘Children Medicine Price’ survey conducted by WHO in Chhatisgarh and Odisha.

 

  • Dr. Kotwani has served as country coordinator on WHO/HAI project on ‘Medicine Prices’ survey carried out in five different states.

 

  • Dr. Kotwani was expert member on Indo-Norway working group on Antimicrobial Stewardship Program, ICMR, India, 2013.

 

  • Dr. Kotwani was expert member on Indo-Swedish project on antimicrobial resistance and rational use of antibiotics, 2012.

 

  • Dr. Kotwani was member on the Task Force Committee, Ministry of Health, Government of India, to develop a National Antibiotic Policy, 2011.

 

She has been invited as an expert nationally and internationally for antibiotic use and consumption, methodology to measure antibiotic consumption, optimum use of antibiotics, awareness for antibiotic use, containment of AMR and promoting access to medicines.  

 

Ongoing funded project

 

  • DBT funded project, “Smart regulation of antibiotic use in India: Understanding, innovating and improving compliance” under India-UK initiative on ‘Antimicrobial Resistance in India’. September 2018 – September 2021. Total budget sanctioned for the project Rs. 136.988 lakhs.

 

Last 10 years completed project

 

·       Effect of Indian almond and sweet almond in diabetes induced nephropathy and cataract in rats. (Funded by CCRAS, AYUSH). 2017

 

·        To Assess the Price and Availability of Essential Medicines in Delhi after the Implementation of the National Pharmaceutical Pricing Policy 2012 - Phase II Study . (Funded by WHO, Country Office, India). 2015

 

·   Awareness of antibiotic resistance and antibiotic prescription for treatment of acute upper  respiratory tract infection and diarrhoea in children: a qualitative study among primary care    doctors and community pharmacists in NCT, Delhi (Funded by WHO, SEARO).  2014

                                                        

·    Prices and availability of common essential medicines under National essential medicines list 2011before implementation of NPPP 2012 and dissemination workshop for stakeholders. (Funded by WHO, Country Office, India). 2013

 

·    Trends of antibiotic use among inpatients of community acquired pneumonia in tertiary care hospital.  2013

 

·      Study of patterns of antibiotic dispensing in pharmacies in Tumkur, Karnataka, India. (Center for Disease Dynamics and Economic & Policy, Washington DC, funded project). 2012                                                                 

·      Medicine prices, availability, affordability and price components in NCT, Delhi – using WHO/HAI methodology. (Funded by WHO, SEARO).  2011

 

·      Effect of tadalafil (a phosphodiesterase- inhibitor) in hypoxia induced pulmonary hypertension in rats. (LSRB, DRDO funded project). 2010

 

·        Factors associated with poor asthma control and poor adherence to asthma treatment: self report by patients in emergency room. 2010

·        Surveillance of antimicrobial resistance and use in the community and in-depth qualitative investigation of various stakeholders for behaviour of antimicrobial drugs use for suitable interventions for rational use of antibiotics. (Funded by WHO). 2009                                                                           

·   Surveillance of use of antibiotics in diarrhoea and acute respiratory infection in the community. (Funded by WHO). 2009

·     Medicine price components study in Delhi, India using WHO/HAI methodology. (Funded by DFID, London).  2007

·  Impact of standard treatment guidelines and patient education on quality of asthma management. (Funded by HAI-AP).  2007

 

Recent publications

 

1. Holloway KA, Kotwani A, Batmanabane G, Santoso B, Ratanawijitrasin S, Henry D. Promoting quality use of medicines in South East Asia: reports from country situational analyses. BMC Health Services Research 2018; 18:526. https://doi.org/10.1186/s12913-018-3333-1

2. Kumar R, Kotwani A. Rising threat of antimicrobial resistance: judicious use of antibiotics is the way forward (Editorial). Indian Journal of Chest Diseases & allied Sciences 2017; 59:165-166.

3. Holloway KA, Kotwani A, Batmanabane G, Puri M, Tisocki K. Antibiotic use in South East Asia and policies to promote appropriate use: reports from country situational analyses. BMJ 2017; 358:j2291 doi: 10.1136/bmj.j2291

4. Behl T, Kotwani A. Omega-3 fatty acids in prevention of diabetic retinopathy. Journal of Pharmacy and Pharmacology 2017; 69: 946-54.

5. Kotwani A, Joshi PC, Jhamb U, Holloway K. Prescriber and dispenser perceptions about antibiotic use in acute uncomplicated childhood diarrhea and upper respiratortory tract infection in New Delhi: Qualitative study.  Indian Journal of Pharmacology 2017; 49:419-431.

6. Behl T, Velpandian T, Kotwani A. Role of altered coagulation-fibrinolytic system in the pathophysiology of diabetic retinopathy. Vascular Pharmacology 2017; 92:1-5.

7. Behl T, Kotwani A. Potential of angiotensin II receptor blockers in the treatment of diabetic retinopathy. Life Sciences 2017, 176: 1-9.

8. Behl T, Kotwani A. Anti-hyperglycemic effect of Terminalia catappa fruit extract in streptozotocin-induced diabetic rats. International Journal of Pharmacy and Pharmaceutical Sciences 2017; 9(4): 212-217.

9. Behl T, Kotwani A. Chinese herbal drugs for the treatment of diabetic retinopathy. Journal of Pharmacy   and Pharmacology 2017; 69(3): 223-235.

10. Behl T, Kotwani A. Proposed mechanisms of Terminalia catappa in hyperglycaemia and associated diabetic complications. Journal of Pharmacy and Pharmacology 2016; 20 69 (2): 123-134.

11. Behl T, Kotwani A. Downregulated Brain-Derived Neurotrophic Factor-Induced Oxidative Stress in the Pathophysiology of Diabetic Retinopathy. Canadian Journal of Diabetes 2016; 41: 241-246.

12. Kotwani A, Wattal C, Joshi PC, Holloway K. Knowledge and perceptions on antibiotic use and   resistance among high school students and teachers in New Delhi, India – A Qualitative       study. Indian Journal of Pharmacology 2016; 48: 365-371.

13. Behl T, Kaur I, Goel H, Kotwani A. Implications of endogenous PPAR-gamma ligand, 15-Deoxy-Delta-12, 14-prostaglandin J2, in diabetic retinopathy. Life Sciences 2016, 153: 93-99.

14. Behl T, Kaur I, Kotwani A. Role of leukotrienes in diabetic retinopathy. Prostaglandins and Other Lipid Mediators 2016; 122: 1-9.

15. Kotwani A, Kumar S, Swain PK, Suri JC, Gaur SN. Antimicrobial drug prescribing patterns for community-acquired pneumonia in hospitalized patients: A retrospective pilot study from New Delhi, India. Indian Journal of Pharmacology 2015; 47:375-382.

16. Behl T, Kotwani A. Possible role of endostatin in the antiangiogenic therapy of diabetic retinopathy. Life Sciences 2015; 135: 131-137.

17. Behl T, Kotwani A.  Exploring the various aspects of pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy. Pharmacological Research 2015; 99:137-48.

18. Behl T, Kotwani A, Kaur I, Goel H. Mechanisms of prolonged lithium therapy-induced nephogenic diabetes insipidus. European Journal of Pharmacology 2015; 755: 27-33.

19. Kotwani A. Access to inhaled therapy in India: availability, price and affordability of asthma medicines. In Respiratory Drug Delivery 2014. Edited by Dalby RN, Byron PR, Peart J, Young PM, Traini D. DHI Publishing; River Grove, IL: 2014; 55-65.

20. Kotwani A, Holloway K. Antibiotic prescribing practice for acute, uncomplicated  respiratory tract infections in primary care settings in New Delhi, India. Tropical medicine & International Health 2014; 19: 761-768.

21. Behl T, Kotwani A. Terminalia catappa in the treatment of diabetes mellitus. Asian Journal of Biochemical and Pharmaceutical Research 2014; 3;1-10.

22. Kotwani A. Tracking medicine prices in the supply chain. Who benefits from the free market in India? Economic & Political Weekly 2013; XLVIII No 52, 104-112.

23. Kotwani A, Holloway K. Access to antibiotics in New Delhi, India: implications for antibiotic policy. Journal of Pharmaceutical Policy and Practice.2013, 6:6. http://www.joppp.org/content/6/1/6

24. Kotwani A. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all. BMC Health Services Research 2013, 13:285 (25 July 2013)

25. Rashid M, Fahim M, Kotwani A. Efficacy of tadalafil in chronic hypobaric hypoxia induced pulmonary hypertension:possible mechanisms. Fundamental and Clinical Pharmacology 2013; 27: 271-278.

26. Kotwani A, Shendge S. Asthma self-management: A study in an emergency room of a chest hospital in Delhi, India. Southern Med Review 2012; 2: 20-25.

27. Shendge S, Deka B, Kotwani A. A cross-sectional evaluation of illness perception about asthma among asthma patients at a referral tertiary care public chest hospital in Delhi, India. International Journal of User-Driven Healthcare 2012; 2: 32-43.

28. Kotwani A. Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability. International Psychiatry 2012;9: 34-36.

29. Kotwani A, Chhabra SK, Tayal V, Vijayan VK. Quality of asthma management in an urban community in Delhi, India. Indian Journal of Medical Research 2012; 135: 184-192. http://www.ijmr.org.in/temp/IndianJMedRes1352184-1108122_030441.pdf

30. Kotwani A, Chhabra SK. Impact of standard treatment guidelines and patient education on asthma control and knowledge in asthmatic patients: a controlled trial in Delhi, India. WHO South-East Asia Journal of Public Health 2012; 1: 42-51.

31. Kotwani A, Roy Chaudhury R, Holloway K. Antibiotic prescribing practices of primary care prescribers for acute diarrhoea in New Delhi, India. Value in Health, 2012; 15: S116-S119.

32. Kotwani A, Wattal C, Katewa S, Joshi P C, Holloway K. Irrational use of antibiotics and role of pharmacists: an insight from a qualitative study in New Delhi, India. Journal of Clinical Pharmacy Therapeutics June 2012, 37: 308–312.

33. Rashid M, Kotwani A, Fahim M. Long-acting phosphodiesterase 5 inhibitor, tadalafil, and superoxide dismutase mimetic, tempol, protect against acute hypoxia-induced pulmonary hypertension in rats. Human and Experimental Toxicology 2011 online published  December 5, 2011 doi: 10.1177/0960327111429138

34. Kotwani A.  Transparency and accountability in public procurement of essential medicines in developing countries. International Journal of User-Driven Healthcare 2011; 1: 15-30. http://www.igi-global.com/article/transparency-accountability-public-procurement-essential/61319

35. Ganguly NK, Arora NK, Chandy SJ, Fairoze MN, Gill JS, Gupta U, Hossain S, Joglekar S, Joshi PC, Kakkar M, Kotwani A, Rattan A, Sudarshan H, Thomas K, Wattal C, Easton A, Laxminarayan R. Rationalizing antibiotic use to limit antibiotic resistance in India . Indian Journal of Medical Research 2011; 134:281-94. 

36. Situational Analysis: Antibiotic Use and Resistance in India. Global Antibiotic Resistance Partnership. Global Antibiotic Resistance Partnership-India National Working Group, Ganguly NK Chairman; Co-author. The Centre for Disease Dynamics, Economics and Policy, Washington DC, New Delhi. 2011.

37. Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M. Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure rats. Journal of Cardiovascular Pharmacology Therapeutics 2011 (August 9 2011 online publication) 1074248411416816

38. Kotwani A, Holloway K. Trends in antibiotic use among outpatients in New Delhi, India. BMC Infectious Diseases 2011;11:99 http://www.biomedcentral.com/1471-2334/11/99

39. Singal G, Nanda A, Kotwani A. A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India. Indian Journal of Pharmacology 2011; 43: 131-136.

40. Holloway K, Mathai E, Gray A, on behalf of Community-based surveillance of antimicrobial use and resistance in resource-constrained settings Project Group (Kotwani A, et al). Surveillance of community antimicrobial resistance in resource-constrained settings – experience from five pilot projects. Tropical Medicine and International Health 2011; 16: 368-374.

41. Holloway K, Mathai E, Gray A, on behalf of Community-based surveillance of antimicrobial use and resistance in resource-constrained settings Project Group (Kotwani A, et al). Surveillance of community antimicrobial use in resource-constrained settings – experience from five pilot projects. Tropical Medicine and International Health 2011; 16: 152-161.

42. Singhal G.L., Kotwani A, Nanda A. Jan Aushadhi stores in India and quality of medicines therein. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3:204-207.

43. Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M. Mechanistic clues in the cardioprotective effect of Terminilia arjuna bark extract in isoproterenol-induced chronic heart failure in rats. Cardiovascular Toxicology 2011; 11; 48-57.

44. Kotwani A, Wattal C, Katewa S, Joshi P C, Holloway K. Antibiotic use in the community: what factors influence primary care physicians to prescribe antibiotics in Delhi, India? Family Practice 2010; 27: 684-690. http://fampra.oxfordjournals.org/content/27/6/684.full

45. Kotwani A. Editorial. Access to essential medicines and standard treatment for chronic diseases. Indian Journal of Pharmacology 2010; 42: 127-128.

46. Kotwani A. Will generic drug stores improve access to essential medicines for the poor in India? Journal of Public Health Policy 2010; 31: 178-184.

47. Kotwani A, Holloway K, Roy Chaudhury R.  Methodology for surveillance of antimicrobials use among out-patient in Delhi. Indian Journal of Medical Research 2009; 129: 555-60.

48. Wattal C, Raveendran R, Kotwani A, Sharma A, Bhandari SK, Sorensen TL, Holloway K. Establishing a new methodology for monitoring of antimicrobial resistance and use in the community in a resource poor-setting. Journal of Applied Therapeutic Research 2009; 7: 37-45.

49. WHO Research Series on Medicine (2009). Community-based surveillance of antimicrobial use and resistance in resource-constrained settings. Report on five pilot projects. Kotwani A (Antimicrobial drug use surveillance, Delhi site).World Health Organization, 2009 WHO/EMP/MAR/2009.2

50. Kotwani A. Availability, price, and affordability of asthma medicines in five Indian states. International Journal of Tuberculosis and Lung Diseases 2009; 13: 574-579.

51. Kotwani A, Gurbani N, Sharma S, Chaudhury R. Insights for policymakers from a medicine price survey in Rajasthan. Indian Journal of Medical Research 2009; 129: 451-454.

 

 

2. Kavita Gulati, Director Professor

 

Dr. Kavita Gulati is Associate Professor in Pharmacology at  Vallabhbhai Patel Chest Institute, University of Delhi. She obtained her masters degree in Pharmacology from the All India Institute of Medical Sciences and subsequently did her Ph.D from the University of Delhi. Dr Gulati has more than 22 years of teaching and research experience in Clinical and Experimental Pharmacology and Toxicology in different capacities in India and abroad. She is the recipient of several national awards including the Achari Prize and Uvnas Prize and the prestigious Prof. B.N. Ghosh Oration of the IPS. She is member of several professional bodies/societies relating to pharmacology and allied sciences (viz. National academy of Medical Sciences, International Neuroendocrine Federation, New York Academy of Sciences, Society of Toxicology, Society of Pharmacovigilance, Indian Pharmacological Society, etc. Her biography has also been include in the Marqui`s “Who is Who” in the world in science.  Her research interests are in Respiratory Pharmacology and Toxicology, Neuropharmacology and Stress Research, and she is the Principal Investigator of several extramurally funded research projects (viz. DST, AYUSH, CSIR, ICMR, etc.). She has the distinction of being invited to present talks at prestigious international meetings like IUPHAR (China), CMB Congress (France), World Stress Congress (Hungary), and CPT Congress (Australia). She has been visiting scientist to reputed international institutions like Semmelwies Medical University (Budapest, Hungary), University of Pittsburgh Medical Center (USA), Army Medical Institute (Xian, China), University of Minnesota at Minneapoilis (USA), University of Illinois at Chicago (USA), etc and expert member at different Institutions and Government organizations in her field. She has published extensively in leading national and international journals, is co-author of several chapters in reference and textbooks of Pharmacology, and co-editor of three books in Pharmacology.
 
Areas of Research :
 
(i)             Respiratory Pharmacology and Toxicology
(ii)           Neuropharmacology & Allied Neurosciences
(iii)         Stress Research
(iv)         Herbal drug research
 
Ongoing and completed research projects:
a) P.I. in the DST funded research project entitled “Pharmacological studies on the role of nitric oxide (NO) in stress adaptation in rats” (Completed).
 
b) P.I. in ICMR funded research project entitled “Studies on the role of NO and NO-mediated signal transduction pathways during stress induced immunomodulation in rats”
 
c) P.I. in CSIR funded project entitled “Experimental studies on the possible role of nitric oxide (NO) during acute and chronic morphine effects in normal and stressed rats”
 
d) P.I. in AYUSH funded project entitled “Experimental studies on the cellular and   molecular mechanisms of action of UNIM-352, a polyherbal Unani preparation, to validate its use as a drug for bronchial asthma”

 
e) Co P.I. in AYUSH funded project entitled “Studies on the possible mechanisms involved in the effects of UNIM-352, a polyherbal, anti-asthmatic Unani preparation, in experimental animals” (completed).

f)Co P.I. in   CCRUM (AYUSH)  project entitled “Pre-clinical studies to evaluate the toxicity profile of (a) UNIM-051 and (b) UNIM-053, polyherbal Unani formulations with therapeutic potential in sinusitis”
 
g) Co P.I. in DRDE  (DRDO, Min. of Defence)  entitled “Pharmacological studies on the role of nitric oxide (NO) and NO-mediated signaling pathways in acute and chronic hypoxia induced behavioral and immunological changes in rats”
 
h) Co P.I. in DBT project entitled “Calcium phosphate nanoparticles co-encapsulating neuro therapeutic gene and drug for targeted therapy of neurodegenerative disorders”
 
 
List of Publication
In indexed Journals :
1) Kheterpal K. Lall SB, Rajdev S, Gupta YK. Effect of calcium channel blockers and saralasin on angiotensin II contractions in rabbit aortic strip. Indian J Physiol Pharmacol 30 : 166-170, 1986.
2) Lall SB, Kheterpal K, Rajdev S, Gupta YK. The effect of acute and chronic treatment of verapamil on pressor response to angiotensin II in rats. Indian J Physiol Pharmacol 30 : 145-148, 1986.
3) Arora RB, Kheterpal K, Khanna T, Khan SU, Khan EA. Efficacy of   standardized, safe, unani, coded drug Ajmaloon, a pharmaceutical preparation containing rauwolfia, Indian J Pharmacol 18: 29-41, 1986.
4) Arora RB, Hardard ME, Kheterpal K. Khanna T, Khan SU, Khan EA. Efficacy of a standardized, safe, unani, coded drug "Lipotab" in hypercholestremia and involvement of zinc in its mechanism. J Res Edu Indian Med 4: 49-56, 1986.
5) Kheterpal K, Khanna T, Arora RB, Siddiqui HH. Study of a Unani polypharmaceutical preparation, Joshina, as anti-tussive and expectorant in experimental model. Indian J Pharmacol. 19 : 200-204, 1987. 
6) Chandra D, Kheterpal K. Use of mating cages for food intake study in rats instead of metabolic cages. Indian J Pharmacol 20: 219-220, 1988.
7) Kheterpal K, Khanna T, Arora RB. In vitro and in vivo bronchorelaxant effect in guinea pigs of "Joshina", a herbal polypharmaceutical. J Ethnopharmacol 26: 183-187. 1989.
8) Arora RB, Kheterpal K, Khanna T, Khan SU. Possible interaction of some trace elements in mechanism of antihypertensive action of a polypharmaceutical, Ajmaloon. J Res Edu Indian Med 8: 17-21, 1989.
9) File SE, Zharkovsky A, Gulati K. Effects of baclofen and nitrendipine on ethanol withdrawal responses in the rats. Neuropharmacology 30: 183-190, 1991.
10) Gulati K, Ray A, Sharma KK. Role of diurnal variation and receptor specificity in the opioidergic regulation of food intake in free-fed and food-deprived rats. Physiol Behav 49: 1065-1071, 1991.
11) Gulati K, Ray A, Sharma KK. Effects of acute and chronic morphine on food- intake in rats: Modulation by oxytocin and vasopressin. Pharmacol Biochem Behav 40: 27-32, 1991.
12) Gulati K, Ray A, Sharma KK. Effect of acute and chronic ketocyclazocine and its modulation by oxytocin or vasopressin on food intake in rats. Pharmacol Biochem Behav 41: 7-12, 1991.
13) Gulati K, Ray A, Sharma KK. Effects of acute or chronic opioid agonist and their modulation by diurnal rhythmicity and satiety states on food intake in rats. Indian J Exp Biol 30: 185-189, 1992.
14) Gulati K, Sharma KK. Opioidergic regulation of food intake : Modulation by vasopressin. Indian J Pharmacol, 25: 18-23, 1993 (Awarded Achari Prize in 25th Annual conference of Indian Pharmacological Society, 1992).
15) Ray A, Gulati K, Puri S, Sen P. Role of kappa opioid receptors during stress responsiveness in rats. Indian J Exp Biol, 31: 116-119, 1993.
16) Ray A, Gulati K, Mediratta PK, Sen P. Opioidergic regulation of gastric ulcerogenesis and immune responsiveness during stress in rats. Exp Clin Gastroenterol, 3: 7-11, 1993.
17) Ray A, Henke PG, Gulati K, Sen P. The amygdaloid Complex, corticotropin releasing factor and stress induced gastric ulcerogenesis in rats. Brain Research, 624: 286-290, 1993.
18) Gulati K, Ray A, Effects of Intrahypothalamic morphine and its interaction with oxytocin and vassopressin during food intake in rats. Brain Research, 690, 99-103, 1995
19) Gulati K. Differential effects of intrahypothalamic administration of opioids on food intake in naive and tolerant rats. Pharmacol Biochem Behav. 52(4): 689-694, 1995
20) Gulati K, Sharma KK, Chandra D. Opioidergic regulation of food - intake. Ann Natl Acad Med Sci 29: 241-306, 1993.
21) Gulati K, Lall SB, Angiotensin-II receptor subtypes, characterization and pathophysiological implication. Indian J Exp Biol. 34: 91-97, 1996.
22) Lall SB, Dass N, Rama R, Peshin SS, Khatar S, Gulati K, Seth SD. Cadmium induced nephrotoxicity in rats. Indian J Exp Biol 35: 151-154, 1997.
23) Lall SB, Peshin SS, Gulati K, Khattar S, Das N, SEth SD. Involvement of renin-angiotensin system in the hypertensive effect of cadmium in rats. Indian J Exp Biol 35: 338-341, 1997.
24) Gulati K, Lall SB, Das BP, Seth SD. Effect of short and long term exposure to diesel exhaust on sensitivity of guinea pig tracheal preparation to histamine. Indian J Exp Biol 35: 837-40, 1997.
25) Lall SB, Das N., Das BP, Gulati K. Biochemical and histopathological changes in respiratory, system of rats following exposure to diesel exhaust. Indian J Exp Biol 36: 55-59, 1998.
26) Lall SB, Singh B, Gulati K, Seth SD. Role of nutrition in toxic injury. Indian J Exp Biol 37: 109-116, 1999.
27) Gulati K, Wardhan N, Anand S, Ray A. Studies on the toxicodynamics of aminophylline – induced seizures in mice. Indian J. Pharmacol. 35: 196-197, 2003.
28) Gulati K, Anand S, Vijayan VK and Ray A. Stress-induced modulation of aminophylline seizures in rats : Possible involvement of free radicals. Indian J Pharmacol. 36 : 270-271, 2004.
29) Gulati K, Ray A, Pal G, Vijayan VK. Possible role of free radicals in theophylline induced seizures in mice. Pharmacol. Biochem, Behav. 82 : 241-245, 2005
30) Ray A, Gulati K, Anand S, Vijayan VK. Pharmacological studies on the mechanisms of aminophylline induced seizures in rats. Indian J Exp Biol. 43: 849 – 853, 2005
31) Gulati K, Ray A. Studies on the mechanisms of anxiolytic and neuropeotective effects of melatonin in rats. Frontiers Neuroendocrinol. 27 : 129 -130, 2006.
32) Gulati K, Ray A, Masood A, Vijayan VK. Involvement of nitric oxide (NO) in   the regulation of stress susceptibility and adaptation in rats. Indian J Exp Biol, 44: 809-815, 2006.
33) Pal R, Gulati K, Banerji BD, Ray A. Role of free radicals in stress-induced neurobehavioral changes in rats. Indian J Exp Biol., 44: 816-820, 2006.
34) Ray A, Gulati K, Tyagi N, Vijayan VK. Adverse drug reactions : an overview. J Pharmacovigil Drug Safety 3 : 4 – 7, 2006.
35) Chakraborti A, Gulati K, Banerjee BD, Ray A. Possible involvement of free radicals in the differential neurobehavioral responses to stress in male and female rats. Behav Brain Res 179 : 321-325, 2007
36) Ray A, A.Chakraborti, Gulati K. Current trends in nitric oxide research. Cell Mol Biol, 53 :3-14, 2007
37) Gulati K, Ray A, Pal R. Free Radicals and Theophylline neurotoxicity :     An experimental study. Cell   Mol Biol, 53 : 42-52, 2007
38) Gulati K, .Chakrabort A, Ray A.  Modulation of stress induced neurobehavioral changes and brain oxidative injury by nitric oxide (NO) mimetics in rats. Behav Brain Res,183: 226-230, 2007.
39) Chakraborti A, Gulati K, Ray A. Estrogen actions on brain and behavior : Recent insights and future challenges. Reviews in Neurosciences, 18: 395-416 2007
40) Chakraborti A, Gulati K, Ray A. Age related changes in stress-induced neurobehavioral effects in rats modulation by antioxidants and nitrergic agents. Behav Brain Res194 (1) : 86-91, 2008
41) Gulati K, .Chakrabort A, Banerji BD, Ray A.  Experimental studies on the anti-oxidant role of nitric oxideduring stress. Indian J Pharmacol40 (Suppl.2): S130, 2008.
42).Tyagi N, Gulati K, Vijayan VK, Ray A. A study to monitor adverse drug reactions in patients of chronic obstructive pulmonary disease: focus on theophylline. Indian J Chest Dis All Sci 50 : 199-202, 2008
43).Gulati K, .Chakraborti A, Ray A. Differential role of nitric oxide (NO) in acute and chronic stress induced neurobehavioral modulation and oxidative injury in rats. Pharmacol Biochem Behav, 92: 272-6, 2009 (Awarded Uvnas prize of Indian pharmacology Society, 2010)
44).Gulati K, Ray A, Vijayan VK Assessment of protective role of polyherbal preparation, Livina against anti-tubercular drug induced liver dysfunction. Indian J Exp Biol. 48:318-322, 2010
45).Gulati K, Banerjee BD, Lall SB, Ray A. Effects of diesel exhaust, heavy metals and pesticides on various organ systems : Possible mechanisms and strategies for prevention and treatment. Indian J Exp Biol. 48:710-721, 2010
46).Gulati K, Chakraborty A, Ray A. Physiological and behavioral correlates of stress induced anxiogenesis in rats: possible role of free radicals. Indian J Pharmacol. 42 (Suppl.2), 128-129, 2011
47).Chakraborti A, Gulati K, Ray A. Involvement of nitric oxide in the protective effects of dehydroepiandrosterone sulphate on stress induced neurobehavioral suppression and brain oxidative injury in rats. Eur J Pharmacol, 652: 55-59, 2011.
48). Rishi Pal, Gulati K, Banerjee B, Ray A. Pharmacological and biochemical studies on the   role of free radicals during stress-induced immunomodulation in rats. International Immunopharmacology, 11:1680-1684, 2011
49). Pal R, Gulati K, Banerji BD, Ray A. Pharmacological and biochemical studies on the protective effects of melatonin during stress-induced neurobehavioral and immunological changes in relation to oxidative stress in rats. J Pineal Res, 2011 (communicated)
50) Anand R, Gulati K, and Ray. Pharmacological evidence for the role of nitric oxide (NO) in the modulation of stress induced anxiety by morphine in rats. Eur J Pharmacol. 2011(communicated).
51) Gulati K, Chakraborty A, Ray A Role of Oestrogen-nitric oxide (NO) interactions in the regulation of gender based differences in stress susceptibility and adaptation in rats. Physiol Behav. 2011(communicated).
 
 
 

Chapters in books

 
1). Arora RB, Subramaniam TAV, Bhatia B, Khan SU, Gaur SN, Kheterpal K. Khanna T. Role of zinc in health and disease. In 'Elements in Health and Disease' (Eds: Said M, Rahman MA & Silva LAD), Pakistan, Hamdard University Press, 1987
 
2). Arora RB, Hameed A, Subramaniam TAB, Roy S, Khan EA, Kheterpal K. Khan SU. Differential serum zinc concentration in some cardivascular diseases and broachial asthma. In "Metabolism of Minerals and Trace Elements in Human diseases" Eds: Abdulla M, Deshti H, Sarkar B, Sayer AH & Nageeb NA), New Delhi Smith-Gordon, 57-60, 1989.
         3). Kheterpal K, Khanna T, Imran M, Khan SU, Arora RB, Hammed A. Effect of "Lipotab" on experimentally induced cardiovascular pathology and its probable mechanism of action. In "Research and Development of Indigenous Drugs" (Eds Dandiya PC and Vohra SB, New Delhi, Interprint ,182-187, 1989.
4). Arora RB, Kheterpal K, Khanna T, Roy S, Khann SU. Role of electrolytes in development of druges for cardiac arrhythmias. In 'Calcium channel blockers and heart (Eds) Seth SD, Manchanda SC, Siddiqui HH. New Delhi, Interprint, 91-96, 1989.
5). Ray A, Masood A, Gulati K, Banerji BD. Stress and Immunity : Mechanisms and Modulations by Drugs . In : Trends in Physiological Sciences : From Cells to Systems (Ed : M. Fahim), New Delhi, Shivam Press, pp. 406 – 423, 2002.
 
6). Gulati K, Ray A . Preventable adverse drug reactions : focus on theophylline. In : Pharmacovigilance : An Update , Eds. A. Ray and K. Gulati , New Delhi Image Graphics India,   pp. 218 – 230, 2004.
7). Ray A, Gulati K. Nitric Oxide and the Central Nervous System : Perspectives and Trends. In : Current Trends in Pharmacology (Eds: A Ray, K Gulati), New Delhi IK International, pp.367-382, 2007.
8). Gulati K, Ray A, Vijayan VK. Free radicals and drug toxicity : Focus on theophylline. In : Current Trends in Pharmacology (Eds: A Ray, K Gulati), New Delhi, IK International, pp.443-460, 2007.
9). Gulati K, Ray A. Immunotoxicity In : Handbook of Toxicology of Chemical Warfare Agents ( ed. R Gupta ), Elsevier Publication, 595-60, 2008.
10). Ray A, Gulati K. Pharmacodynamics . In : Textbook of Pharmacology (Ed. Prof. S.D. Seth), , New Delhi, Elsevier Publication, 2009
11). Ray A, Gulati K. Pharmacokinetics . In : Textbook of Pharmacology (Ed. Prof. S.D. Seth and Vimlesh Seth), New Delhi, Elsevier Publication, 2009
 12). Gulati K, Ray A. Newer insights into the mechanisms of action of some herbal     adaptogens. In : Recent advances in Herbal Drug Research and Therapy ( Ed. A Ray, K Gulati), New Delhi, IK International, 201-218, 2009
13) Gulati K, Ray A. Stress: its impact on developmental and reproductive toxicology. In: Handbook of reproductive and developmental toxicology, (ed. R Gupta), Amsterdam, Elsevier Publication.825-834, 2010
 
 
 
In Non-Indexed journals
 
1).Lall SB, Gulati K, Trandolapril, Drug Alert. 4(2): 41-44, 1995.
2).Gulati K, Lall SB. Exposure of population to PVC fire: A focus on dioxins. Drug Alert 5:34-40, 1996.
3).Kheterpal K, Siddiqui TO. Nepeta Hindostana (roth) Haines, a cardioprotective unani drug. Hamdard Medicus 32: 35-43, 1989.
4).Gulati K, Ray A, Debnath PK, Bhattacharya SK. Immunomodulatory Indian   Medicinal Plants. J. Nat. Remed. 2 (2): 121 – 131, 2002.
 
 
Books (As Co-Editor)

1) Pharmacovigilance : An Update (Eds: Arunabha Ray and Kavita Gulati), Image Graphics, Delhi, 2004

2) Current Trends in Pharmacology (Eds: Arunabha Ray and Kavita Gulati), IK International, Delhi, 2007

3) Recent advances in herbal drug research and therapy (Eds. Arunabha Ray and Kavita Gulati, IK International, New Delhi, 2009

 3. Dr. Ajita Kapur, Assistant Professor